Home/Filings/4/0000950170-25-088093
4//SEC Filing

Chapman Peter Hume 4

Accession 0000950170-25-088093

CIK 0001824920other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 9:00 PM ET

Size

14.2 KB

Accession

0000950170-25-088093

Insider Transaction Report

Form 4
Period: 2025-06-16
Chapman Peter Hume
DirectorExecutive Chair
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-17$0.13/sh+910,740$121,4931,301,069 total
  • Exercise/Conversion

    Common Stock

    2025-06-16$0.13/sh+3,581,193$477,7313,971,522 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-06-17$0.13/sh910,740$121,4931,604,972 total
    Exercise: $0.14Exp: 2029-05-16Common Stock (8,096,905 underlying)
  • Sale

    Common Stock

    2025-06-16$38.13/sh3,581,193$136,536,564390,329 total
  • Sale

    Common Stock

    2025-06-17$37.78/sh910,740$34,406,573390,329 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-06-16$0.13/sh3,581,193$477,7312,515,712 total
    Exercise: $0.14Exp: 2029-05-16Common Stock (8,096,905 underlying)
Footnotes (4)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.0450 to $39.1450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.87 to $38.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]All of the shares subject to this option are fully vested and exercisable as of the date hereof

Documents

1 file

Issuer

IonQ, Inc.

CIK 0001824920

Entity typeother

Related Parties

1
  • filerCIK 0001885490

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:00 PM ET
Size
14.2 KB